Skip to main content
Clinical Trials/ACTRN12624000755538
ACTRN12624000755538
Not yet recruiting
未知

Positron Emission Tomography with AT-01 to Diagnose and Monitor Amyloidosis: A Prospective Cohort Pilot Study in Adult Patients.

Metro South Health0 sites30 target enrollmentJune 19, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Amyloidosis
Sponsor
Metro South Health
Enrollment
30
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 19, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Metro South Health

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of amyloidosis with the known following subtype:
  • (a) Systemic AL amyloidosis prior to therapy commencement (n\=15\)
  • (b) Systemic AL amyloidosis with suboptimal response to therapy or in early biochemical relapse (n\=5\)
  • (c) ATTRwt amyloidosis (n\=5\)
  • (d) Other systemic amyloidosis i.e. ALECT2 and Alys amyloidosis (n\=5\)
  • 2\. Age equal to or greater than 18yrs
  • 3\. Life expectancy greater than 3 months

Exclusion Criteria

  • 1\.Localised amyloidosis
  • 2\.Known iodine or potassium iodide hypersensitivity
  • 3\.Patients being treated with heparin and heparin like anticoagulant therapy (due to interaction with AT\-01\)
  • 4\.Patients who are pregnant and/or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials